EUVIMEDEUVIMED entdecken
Crossref

The utility of miRNA 221 & miRNA 199-a in the diagnosis of pancreatic adenocarcinoma

Yosra Ayman Yosry, Aisha Elsharkawy, Hussein Hassan Okasha, Rabab Fouad, Ahmed Khairy, Olfat Shaker, Hany Khattab, Ayman Yosry, Younan Kabara Ayoub

Arab Journal of Gastroenterology · 2025

DOI: 10.1016/j.ajg.2025.09.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arab Journal of Gastroenterology, 2025. Verfasst von Yosra Ayman Yosry und 8 weiteren Autor:innen. Beteiligte Einrichtung: Ministry of Health, Egypt. Electronic address: yosraayman@gmail.com. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, MicroRNAs, Carcinoma, Pancreatic Ductal, Adenocarcinoma. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Cairo University, Science and Technology Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Pancreatic cancer (PC) is the fourth leading cause of cancer-related mortality, with pancreatic ductal adenocarcinoma (PDAC) being the most common subtype. PDAC is often diagnosed at advanced stages due to lack of symptoms and reliable early biomarkers. AIM: This study aimed to evaluate the diagnostic utility of serum miRNA 221 and miRNA 199-a in PDAC and their association with disease progression. It also examined the correlation of the neutrophil-to-lymphocyte ratio (NLR) and the platelet-to-lymphocyte ratio (PLR) with tumor resectability and disease progression. METHODS: A total of 110 subjects (55 PDAC and 55 healthy controls) were recruited.Blood samples were collected to measure the serum miRNA 221, serum miRNA 199-a, neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR). Diagnosis of pancreatic ductal adenocarcinoma (PDAC) was confirmed via endoscopic ultrasound-guided fine needle biopsy (EUS-FNB). Patients were followed for six months to monitor their disease progression. RESULTS: Serum miRNA 221 and miRNA 199-a levels were significantly elevated in pancreatic adenocarcinoma patients (p = 0.009 and p = 0.001, respectively), with miRNA 221 correlating with tumor size (r = 0.343, p = 0.01). Advanced tumor stage (T3, T4) was linked to higher miRNA 221 and NLR levels (p = 0.017, p = 0.01). Additionally, lower NLR levels were associated with tumor resectability (p < 0.001) and improved survival (p < 0.001). CONCLUSIONS: These findings suggest that miRNA 221 and miRNA 199-a may serve as diagnostic markers for PDAC. While miRNA 221 and NLR are valuable prognostic indicators for tumor progression and patient survival in PDAC. Further validation in larger cohorts and across pancreatic and other gastrointestinal malignancies is needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsMicroRNAsCarcinoma, Pancreatic DuctalAdenocarcinomaHumansMaleFemaleMiddle AgedBiomarkers, TumorAgedDisease ProgressionNeutrophilsCase-Control StudiesEndoscopic Ultrasound-Guided Fine Needle AspirationBlood PlateletsLymphocytesAdultLymphocyte Count

Stichwörter der Autor:innen

Neutrophil lymphocyte ratioPancreatic ductal adenocarcinomaPlatelet lymphocyte ratiomiRNA 199-amiRNA 221

Substanzen

MicroRNAsBiomarkers, TumorMIR221, human

Autor:innen und Institutionen

  • Ministry of Health, Egypt. Electronic address: yosraayman@gmail.com.
  • Endemic Medicine Department, Faculty of Medicine, Cairo University, Egypt.
  • Internal Medicine Department Faculty of Medicine, Cairo University, Egypt.
  • Medical Biochemistry and Molecular Biology Faculty of Medicine ,Cairo University, Egypt.
  • Pathology Department, Faculty of Medicine, Cairo University, Egypt.

Förderung

  • Cairo University
  • Science and Technology Development Fund

Zitieren

APA

Yosry, Y. A., Elsharkawy, A., Okasha, H. H., Fouad, R., Khairy, A., Shaker, O., Khattab, H., Yosry, A., & Ayoub, Y. K. (2025). The utility of miRNA 221 & miRNA 199-a in the diagnosis of pancreatic adenocarcinoma. Arab Journal of Gastroenterology. https://doi.org/10.1016/j.ajg.2025.09.005

Vancouver

Yosry YA, Elsharkawy A, Okasha HH, Fouad R, Khairy A, Shaker O, et al. The utility of miRNA 221 & miRNA 199-a in the diagnosis of pancreatic adenocarcinoma. Arab Journal of Gastroenterology. 2025. doi:10.1016/j.ajg.2025.09.005

BibTeX
@article{Yosry2025,
  author = {Yosry, Yosra Ayman and Elsharkawy, Aisha and Okasha, Hussein Hassan and Fouad, Rabab and Khairy, Ahmed and Shaker, Olfat and Khattab, Hany and Yosry, Ayman and Ayoub, Younan Kabara},
  title = {The utility of miRNA 221 & miRNA 199-a in the diagnosis of pancreatic adenocarcinoma},
  journal = {Arab Journal of Gastroenterology},
  year = {2025},
  doi = {10.1016/j.ajg.2025.09.005}
}
Kostenlos starten →